Staphylococcus hominis native mitral valve bacterial endocarditis (SBE) in a patient with hypertrophic obstructive cardiomyopathy

Heart and Lung: Journal of Acute and Critical Care

Volumn 36, Issue 5, 2007, Pages 380-382

  Cunha, Burke A ^a,b   Esrick, Michael D ^a   LaRusso, Melissa ^a  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; VANCOMYCIN;

ADULT; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIAL VIRULENCE; BLOOD CULTURE; CASE REPORT; COAGULASE NEGATIVE STAPHYLOCOCCUS; DYSPNEA; FATIGUE; FEVER; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MALE; PRIORITY JOURNAL; PROSTHESIS; SKIN FLORA; STAPHYLOCOCCUS HOMINIS; SUBACUTE ENDOCARDITIS; SYSTOLIC HEART MURMUR;

CARDIOMYOPATHY, HYPERTROPHIC; ENDOCARDITIS, SUBACUTE BACTERIAL; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS HOMINIS;

EID: 34548451586     PISSN: 01479563     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrtlng.2006.11.002     Document Type: Article

References (15)

1. Miele P.S., Kogulan P.K., Levy C.S., et al. Seven cases of surgical native valve endocarditis caused by coagulase-negative staphylococci: an underappreciated disease. Am Heart J 142 (2001) 571-576
2. Etienne J., and Eykyn S.J. Increase in native valve endocarditis caused by coagulase negative staphylococci: an Anglo-French clinical and microbiological study. Br Heart J 64 (1990) 381-384
3. Von Eiff C., Peters G., and Heilmann C. Pathogenesis of infections due to coagulase-negative Staphylococci. Lancet Infect Dis 2 (2002) 677-685
4. Zinkernagel A.S., Speck R.F., Ruef C., et al. Rapidly destructive staphylococcus epidermidis endocarditis. Infection 33 (2005) 148-150
5. Caputo G.M., Archer G.L., Calderwood S.B., et al. Native valve endocarditis due to coagulase-negative staphylococci: critical and microbiological features. Am J Med 83 (1987) 619-625
6. Chu V.H., Cabell C.H., Abrutyn E., et al. Native valve endocarditis due to coagulase-negative staphylococci: report of 99 episodes from the international collaboration on endocarditis merged database. Clin Infect Dis 39 (2004) 1527-1530
7. In: Weinstein L., and Brusch J.L. (Eds). Infective Endocarditis (1996), Oxford University Press, Inc, New York
8. Cunha B.A., Gill V., and Lazar J. Acute infective endocarditis: diagnostic and therapeutic approach. Infect Dis Clin North Am 10 (1996) 811-834
9. Roberts W.C., Kishel J.C., McIntosh C.L., et al. Severe mitral or aortic valve regurgitation, or both, requiring valve replacement for infective endocarditis complicating hypertrophic cardiomyopathy. J Am Colleg Cardiol 19 (1992) 365-371
10. Maron M.S., Olivotto I., Betocchi S., et al. Effect of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. N Engl J Med 348 (2003) 295-303
11. Spirito P., Rapezzi C., Bellon P., et al. Infective endocarditis in hypertrophic cardiomyopathy: prevalence, incidence, and indication for antibiotic prophylaxis. Circulation 99 (1999) 2132-2137
12. Kessler R.B., Kimbrough III R.C., and Jones S.R. Infective endocarditis caused by Staphylococcus hominis after vasectomy. Clin Infect Dis 27 (1998) 216-217
13. Morgan-Hughes G., and Motwani J. Mitral valve endocarditis in hypertrophic cardiomyopathy: case report and literature review. Heart 87 (2002) e8
14. Cunha B.A. S. aureus bacteremia: clinical therapeutic guidelines. Antibiotic for Clinicians 10 (2006) 365-367
15. Cunha B.A. Persistent S. aureus bacteremia: a clinical pathway for diagnosis & treatment. Antibiotic for Clinicians 10 S1 (2006) 39-46